Related Experiment Video
Updated: Aug 11, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Effect of antidiuretic hormone and indomethacin on intrarenal microsphere distribution
Abstract:
The purpose of the present study was to reexamine the effect of antidiuretic hormone (ADH) and indomethacin (IM) on intrarenal blood flow distribution by applying the microsphere technique to trained consciuous dogs. ADH and IM were given separately and jointly during maximal water diuresis. ADH in itself caused moderate antidiuresis and marked natriuresis. Although IM by itself had no significant effect on urinary osmotic concentration or solute excretion it greatly enhanced the antidiuretic effect of ADH and abolished its natriuretic effect. Intrarenal blood flow distribution remained unchanged when ADH and IM were given separately but it was shifted toward the inner cortex when the drugs were administered simultaneously. Furthermore, transition from spontaneous antidiuresis to maximal water diuresis did not alter intrarenal blood flow distribution. The results indicate that ADH induced antidiuresis is dissociated from changes in intracortical blood flow distribution. However, the possibility that IM enhancement of ADH mediated antidiuresis is at least in part mediated by intrarenal hemodynamic changes cannot be excluded.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

